NGNE logo

Neurogene Inc. (NGNE)

Profile

Full Name

Neurogene Inc.

Ticker

NASDAQ: NGNE

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

March 7, 2014

Indexes

Not included

Website

https://www.neurogene.com

Employees

107

Key Details

Price

$31.06(-9.34%)

Market Cap

$443.29M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$925.00K(100.00% YoY)

Annual EPS

-$4.28(-51.05% YoY)

PE Ratio

-

Next earnings date

Nov 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $31.06
    NGNE price is $31.06

    30-Day Relative Volume

    2.35
    NGNE 30-day relative volume is 2.35

    Price Performance

    Price Most Recent Change

    -9.34%
    NGNE price was down -9.34% on Nov 3, 2025

    Price YTD Change

    +35.87%
    NGNE price is up +35.87% since January 1st

    Price 1-Year Change

    -52.94%
    NGNE price is down -52.94% year-on-year

    Price 3-Year Change

    +187.59%
    NGNE price is up +187.59% over the past 3 years

    Price Range

    Price All-Time High

    $1115.00
    NGNE price is currently -97.21% below its historical high of $1115.00

    Price 3-Year Low

    $6.88
    NGNE price is currently +351.78% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $443.29M
    NGNE market cap is $443.29 million

    Market Cap 3-Year Change

    +1827.26%
    NGNE market cap is up +1827.26% over the past 3 years

    Market Cap All-Time High

    $2.81B
    NGNE market cap is currently -84.24% below its historical high of $2.81 billion

    Market Cap Sector Percentile

    60.77%
    NGNE market cap is higher than 60.77% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +9.69%
    NGNE shares outstanding is up +9.69% year-on-year

    Shares Outstanding 3-Year Change

    +570.14%
    NGNE shares outstanding is up +570.14% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.90
    NGNE beta is 1.90

    200-day SMA

    $19.00
    NGNE price is currently +63.46% above its 200-day simple moving average

    50-day SMA

    $23.74
    NGNE price is currently +30.81% above its 50-day simple moving average

    14-Day RSI

    56.02
    NGNE 14-day relative strength index is 56.02

    Volume

    2.35
    NGNE 30-day relative volume is 2.35

    ATR

    $3.27
    NGNE average true range is $3.27

    10-day Historical Volatility

    85.73%
    NGNE 10-day historical volatility is 85.73%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $925.00K
    NGNE annual revenue is $925.00 thousand

    Revenue Analysts Estimate

    -
    NGNE annual revenue consensus analysts' forecast is unknown

    Revenue 1-Year Change

    +100%
    NGNE annual revenue is up +100% year-on-year

    Revenue Sector Percentile

    36.78%
    NGNE annual revenue is higher than 36.78% of companies in Healthcare sector

    EPS

    EPS

    -$4.28
    NGNE annual earnings per share is -$4.28

    EPS Analysts Estimate

    -$4.32
    NGNE annual earnings per share is currently +0.98% higher than the consensus analysts' forecast

    EPS 1-Year Change

    -51.05%
    NGNE annual earnings per share is down -51.05% year-on-year

    EPS Sector Percentile

    23.18%
    NGNE annual earnings per share is higher than 23.18% of companies in Healthcare sector

    Profit

    Gross Profit

    -$2.32M
    NGNE annual gross profit is -$2.32 million

    Gross Margin

    -251.03%
    NGNE annual gross profit margin is -251.03%

    Operating Profit

    -$82.61M
    NGNE annual operating income is -$82.61 million

    Operating Margin

    -8930.27%
    NGNE annual operating profit margin is -8930.27%

    Net Income

    -$75.14M
    NGNE annual net profit is -$75.14 million

    Net Margin

    -8123.68%
    NGNE annual net profit margin is -8123.68%

    Expenses

    Total Expenses

    $76.07M
    NGNE annual total expenses is $76.07 million

    Operating Expenses

    $80.28M
    NGNE annual total operating expenses is $80.28 million

    Cost Of Goods Sold

    $3.25M
    NGNE annual cost of goods sold is $3.25 million

    Selling, General & Administrative Expenses

    $0.00
    NGNE annual SG&A is $0.00

    Depreciation & Amortization

    $3.19M
    NGNE annual D&A is $3.19 million

    Interest Expense

    $0.00
    NGNE annual interest expense is $0.00

    Income Tax

    $0.00
    NGNE annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$82.61M
    NGNE annual earnings before interest & taxes is -$82.61 million

    EBITDA

    -$79.36M
    NGNE annual EBITDA is -$79.36 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $336.44M
    NGNE annual total assets is $336.44 million

    Non Current Assets

    $19.81M
    NGNE annual long term assets is $19.81 million

    Current Assets

    $315.92M
    NGNE annual total current assets is $315.92 million

    Cash and Cash Equivalents

    $312.40M
    NGNE annual cash & cash equivalents is $312.40 million

    Accounts Receivable

    -
    NGNE annual accounts receivable value is unknown

    Inventory

    $0.00
    NGNE annual inventory is $0.00

    Liabilities

    Total Liabilities

    $26.07M
    NGNE annual total liabilities is $26.07 million

    Long Term Liabilities

    $1.48M
    NGNE annual total long term liabilities is $1.48 million

    Current Liabilities

    $15.16M
    NGNE annual current liabilities is $15.16 million

    Accounts Payable

    $1.34M
    NGNE annual accounts payable is $1.34 million

    Debt

    Total Debt

    $12.43M
    NGNE annual total debt is $12.43 million

    Total Debt 1-Year Change

    -16.97%
    NGNE annual total debt is down -16.97% year-on-year

    Long Term Debt

    $9.43M
    NGNE annual long term debt is $9.43 million

    Short Term Debt

    $3.00M
    NGNE annual short term debt is $3.00 million

    Equity & Capital

    Shareholders Equity

    $310.38M
    NGNE annual stockholders equity is $310.38 million

    Book Value

    $310.38M
    NGNE annual book value is $310.38 million

    Retained Earnings

    -$262.30M
    NGNE annual retained earnings is -$262.30 million

    Working Capital

    $300.77M
    NGNE annual working capital is $300.77 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$70.60M
    NGNE annual cash from operations is -$70.60 million

    Cash From Operations 1-Year Change

    -37.3%
    NGNE annual cash from operations is down -37.3% year-on-year

    Cash From Investing

    -$125.26M
    NGNE annual cash from investing is -$125.26 million

    Cash From Investing 1-Year Change

    -588.59%
    NGNE annual cash from investing is down -588.59% year-on-year

    Cash From Financing

    $184.07M
    NGNE annual cash from financing is $184.07 million

    Cash From Financing 1-Year Change

    +99.03%
    NGNE annual cash from financing is up +99.03% year-on-year

    CAPEX

    CAPEX

    $808.00K
    NGNE annual capital expenditures is $808.00 thousand

    CAPEX 1-Year Change

    +151.71%
    NGNE annual capital expenditures is up +151.71% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$71.41M
    NGNE annual free cash flow is -$71.41 million

    Free Cash Flow 1-Year Change

    -38.01%
    NGNE annual free cash flow is down -38.01% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    -251.03%
    NGNE annual gross profit margin is -251.03%

    Operating Margin

    -8930.27%
    NGNE annual operating profit margin is -8930.27%

    Net Margin

    -8123.68%
    NGNE annual net profit margin is -8123.68%

    ROA & ROE

    ROA

    -26.88%
    NGNE annual return on assets is -26.88%

    ROE

    -30.28%
    NGNE annual return on equity is -30.28%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    NGNE price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    NGNE price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    1.62
    NGNE price to book ratio is 1.62

    PB Ratio Sector Percentile

    46.12%
    NGNE price to book ratio is higher than 46.12% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    -
    NGNE price to sales ratio value is unknown

    PS Ratio Sector Percentile

    -
    NGNE price to sales ratio is unknown

    Enterprise value

    Enterprise Value

    $179.73M
    NGNE enterprise value is $179.73 million

    Enterprise Value Sector Percentile

    52.12%
    NGNE enterprise value is higher than 52.12% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -1.94
    NGNE EV/EBITDA is -1.94

    EV/EBITDA Sector Percentile

    39.33%
    NGNE EV/EBITDA is higher than 39.33% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    20.84
    NGNE annual current ratio is 20.84

    Quick Ratio

    20.84
    NGNE annual quick ratio is 20.84

    Leverage

    Debt To Equity

    0.04
    NGNE annual debt to equity ratio is 0.04

    Interest Coverage Ratio

    -
    NGNE annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    -
    NGNE piotroski f-score value is unknown

    Altman Z-Score

    9.38
    NGNE altman z-score is 9.38

    Analyst ratings

    Recent major analysts updates

    Oct 31, 25 HC Wainwright & Co.
    Buy
    Oct 9, 25 HC Wainwright & Co.
    Buy
    Jun 17, 25 Craig-Hallum
    Buy
    Jun 12, 25 BMO Capital
    Outperform
    May 20, 25 BMO Capital
    Outperform
    May 16, 25 Baird
    Neutral
    May 13, 25 HC Wainwright & Co.
    Buy
    Apr 14, 25 BMO Capital
    Outperform
    Mar 25, 25 HC Wainwright & Co.
    Buy
    Mar 25, 25 Baird
    Outperform

    Institutional Ownership

    Screeners with NGNE included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    • What is the ticker symbol for Neurogene Inc.?
    • Does Neurogene Inc. pay dividends?
    • What sector is Neurogene Inc. in?
    • What industry is Neurogene Inc. in?
    • What country is Neurogene Inc. based in?
    • When did Neurogene Inc. go public?
    • Is Neurogene Inc. in the S&P 500?
    • Is Neurogene Inc. in the NASDAQ 100?
    • Is Neurogene Inc. in the Dow Jones?
    • When was Neurogene Inc.'s last earnings report?
    • When does Neurogene Inc. report earnings?

    What is the ticker symbol for Neurogene Inc.?

    The ticker symbol for Neurogene Inc. is NASDAQ:NGNE

    Does Neurogene Inc. pay dividends?

    No, Neurogene Inc. does not pay dividends

    What sector is Neurogene Inc. in?

    Neurogene Inc. is in the Healthcare sector

    What industry is Neurogene Inc. in?

    Neurogene Inc. is in the Biotechnology industry

    What country is Neurogene Inc. based in?

    Neurogene Inc. is headquartered in United States

    When did Neurogene Inc. go public?

    Neurogene Inc.'s initial public offering (IPO) was on March 7, 2014

    Is Neurogene Inc. in the S&P 500?

    No, Neurogene Inc. is not included in the S&P 500 index

    Is Neurogene Inc. in the NASDAQ 100?

    No, Neurogene Inc. is not included in the NASDAQ 100 index

    Is Neurogene Inc. in the Dow Jones?

    No, Neurogene Inc. is not included in the Dow Jones index

    When was Neurogene Inc.'s last earnings report?

    Neurogene Inc.'s most recent earnings report was on August 11, 2025

    When does Neurogene Inc. report earnings?

    The next expected earnings date for Neurogene Inc. is November 14, 2025
    On this page